Skip to main content
SpringerLink
Log in

Pro und Kontra

Vorhofohrverschluss für Patienten mit Vorhofflimmern

  • Fortbildung
  • Schwerpunkt Kardiologie
  • Published:
CardioVasc Aims and scope

An der Frage, ob der katheterbasierte Verschluss des linken Vorhofohrs bei Patienten mit Vorhofflimmern eine ebenso wirksame — oder gar bessere — Schlaganfallprophylaxe ist, wie eine orale Antikoagulation, scheiden sich die Geister. Für welche Therapie gibt es die bessere Evidenz? Lesen Sie, was unsere Experten dazu sagen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Reddy VY, Sievert H, Halperin J et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988–98

    Article  CAS  PubMed  Google Scholar 

  2. Holmes DR Jr., Kar S, Price MJ et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12

    Article  PubMed  Google Scholar 

  3. Price MJ, Reddy VY, Valderrabano M et al. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. JACC Cardiovasc Interv. 2015;8:1925–32

    Article  PubMed  Google Scholar 

  4. Bergmann MW, Ince H, Kische S et al. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study. EuroIntervention. 2018;13:2003–11

    Article  PubMed  Google Scholar 

  5. Reddy VY, Gibson DN, Kar S et al. Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. J Am Coll Cardiol. 2017;69:253–61

    Article  PubMed  Google Scholar 

  6. Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42

    Article  CAS  PubMed  Google Scholar 

  7. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51

    Article  CAS  PubMed  Google Scholar 

  8. Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91

    Article  CAS  PubMed  Google Scholar 

  9. Granger CB, Alexander JH, McMurray JJ et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.

    Article  CAS  PubMed  Google Scholar 

  10. Kachroo S, Hamilton M, Liu X et al. Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation. Am J Manag Care. 2016;22:e1–8

    PubMed  Google Scholar 

  11. Reddy VY, Akehurst RL, Amorosi SL et al. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation. Stroke. 2018;49:1464–70

    Article  PubMed  PubMed Central  Google Scholar 

  12. Reddy VY, Akehurst RL, Armstrong SO et al. Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace. 2016;18:979–86

    Article  PubMed  PubMed Central  Google Scholar 

  13. Blackshear JL and Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9

    Article  CAS  PubMed  Google Scholar 

Literatur

  1. Lip GY, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–72

    Article  PubMed  Google Scholar 

  2. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation. Ann Intern Med. 2007;146:857–67

    Article  PubMed  Google Scholar 

  3. ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG et al. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. N Engl J Med. 2009;360:2066–78

    Article  Google Scholar 

  4. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12

    Article  CAS  Google Scholar 

  5. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2009;361:1139–51

    Article  CAS  PubMed  Google Scholar 

  6. Ruff CT, Giugliano RP, Braunwald E et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955–62

    Article  CAS  PubMed  Google Scholar 

  7. Holmes DR, Reddy VY, Turi ZG et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42

    Article  CAS  PubMed  Google Scholar 

  8. Price MJ, Reddy VY, Valderrábano M et al. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. JACC Cardiovasc Interv. 2015;8:1925–32

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CardioVasculäres Centrum, Seckbacher Landstr. 65, 60389, Frankfurt am Main, Deutschland

    Horst Sievert &  Stefan Bertog

  2. Klinik für Kardiologie, Angiologie, Nephrologie und konservative Intensivmedizin, Vivantes Klinikum Neukölln, Rudower Str. 48, 12351, Berlin, Deutschland

    Harald Darius

Authors
  1. Horst Sievert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefan Bertog
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Harald Darius
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Horst Sievert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sievert, H., Bertog, S. & Darius, H. Vorhofohrverschluss für Patienten mit Vorhofflimmern. CV 18, 32–34 (2018). https://doi.org/10.1007/s15027-018-1403-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-018-1403-2

Search

Navigation